54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Jul 31
00:43 UTC
|
BEI.UN
Boardwalk Real Estate Investment Trust
|
◎ Target | firm only | Outperform | C$81.00→ C$84.00+3.7% |
|
Jul 31
00:43 UTC
|
BE
Bloom Energy
|
◎ Target | Praneeth Satish ★★★☆☆ #2254 | Equal Weight | $217.00→ $176.00-18.9% |
|
Jul 31
00:43 UTC
|
BCYC
Bicycle Therapeutics
|
◎ Target | Ami Fadia ★★★☆☆ #2084 | Buy | $15.00→ $14.00-6.7% |
|
Jul 31
00:43 UTC
|
AXS
Axis Capital
|
◎ Target | Elyse Greenspan ★★★★☆ #451 | Overweight | $134.00→ $126.00-6.0% |
|
Jul 31
00:43 UTC
|
AXGN
AxoGen
|
◎ Target | Yi Chen ★★☆☆☆ #2405 | Buy | $50.00→ $53.00+6.0% |
|
Jul 31
00:43 UTC
|
AXGN
AxoGen
|
◎ Target | Caitlin Roberts ★★★★☆ #735 | Buy | $50.00→ $55.00+10.0% |
|
Jul 31
00:43 UTC
|
AXGN
AxoGen
|
◎ Target | David Turkaly ★★★☆☆ #1905 | Market Outperform | $50.00→ $55.00+10.0% |
|
Jul 31
00:43 UTC
|
AVTR
Avantor
|
◎ Target | Brandon Couillard ★★★★☆ #462 | Overweight | $14.00→ $16.00+14.3% |
|
Jul 31
00:43 UTC
|
AVTR
Avantor
|
◎ Target | Tejas Savant not yet tracked | Equal Weight | $10.00→ $14.00+40.0% |
|
Jul 31
00:43 UTC
|
AVTR
Avantor
|
◎ Target | Daniel Arias ★★★★★ #29 | Hold | $8.00→ $15.00+87.5% |
|
Jul 31
00:43 UTC
|
AVTR
Avantor
|
◎ Target | Dan Leonard ★★★★★ #120 | Sec→ r Perform | $9.00→ $14.00+55.6% |
|
Jul 31
00:43 UTC
|
ASH
Ashland
|
◎ Target | Joshua Spector ★★★☆☆ #1727 | Buy | $75.00→ $83.00+10.7% |
|
Jul 31
00:43 UTC
|
ARWR
Arrowhead Pharmaceuticals
|
◎ Target | Madison El-Saadi not yet tracked | Buy | $101.00→ $123.00+21.8% |
|
Jul 31
00:43 UTC
|
ARM
ARM
|
◎ Target | Joe Quatrochi not yet tracked | Overweight | $350.00→ $280.00-20.0% |
|
Jul 31
00:43 UTC
|
ARM
ARM
|
◎ Target | Timothy Arcuri ★★☆☆☆ #2448 | Buy | $360.00→ $320.00-11.1% |
|
Jul 31
00:43 UTC
|
ARM
ARM
|
◎ Target | Krish Sankar ★★☆☆☆ #2381 | Buy | $475.00→ $350.00-26.3% |
|
Jul 31
00:43 UTC
|
ARM
ARM
|
◎ Target | Srini Pajjuri ★★☆☆☆ #2445 | Outperform | $475.00→ $340.00-28.4% |
|
Jul 31
00:43 UTC
|
ARM
ARM
|
◎ Target | Lee Simpson ★★☆☆☆ #2278 | Equal Weight | $202.00→ $212.00+5.0% |
|
Jul 31
00:43 UTC
|
ARCC
Ares Capital
|
◎ Target | Arren Cyganovich ★★★★☆ #675 | Buy | $22.00→ $21.00-4.5% |
|
Jul 31
00:43 UTC
|
ARCC
Ares Capital
|
◎ Target | Paul Johnson ★★★☆☆ #1265 | Outperform | $21.00→ $20.00-4.8% |
|
Jul 31
00:43 UTC
|
ARCB
ArcBest
|
◎ Target | Jason H. not yet tracked | Hold | $175.00→ $155.00-11.4% |
|
Jul 31
00:43 UTC
|
AR
Antero Resources
|
◎ Target | Betty Jiang ★★★☆☆ #1535 | Equal Weight | $45.00→ $46.00+2.2% |
|
Jul 31
00:43 UTC
|
APH
Amphenol
|
◎ Target | Andrew Buscaglia ★★★☆☆ #2178 | Outperform | $200.00→ $215.00+7.5% |
|
Jul 31
00:43 UTC
|
APH
Amphenol
|
◎ Target | William Stein ★★☆☆☆ #2647 | Buy | $200.00→ $215.00+7.5% |
|
Jul 31
00:43 UTC
|
APH
Amphenol
|
◎ Target | Asiya Merchant ★★★☆☆ #1574 | Buy | $195.00→ $210.00+7.7% |
|
Jul 31
00:43 UTC
|
APAM
Artisan Partners Asset Management
|
◎ Target | Kenneth S. Lee not yet tracked | Outperform | $44.00→ $45.00+2.3% |
|
Jul 31
00:43 UTC
|
APAM
Artisan Partners Asset Management
|
◎ Target | Bill Katz not yet tracked | Hold | $35.00→ $37.00+5.7% |
|
Jul 31
00:43 UTC
|
AON
AON
|
◎ Target | Elyse Greenspan ★★★★☆ #451 | Overweight | $406.00→ $419.00+3.2% |
|
Jul 31
00:43 UTC
|
AON
AON
|
◎ Target | Paul Newsome ★★★★★ #140 | Neutral | $377.00→ $391.00+3.7% |
|
Jul 31
00:43 UTC
|
AON
AON
|
◎ Target | Matthew Heimermann ★★★★★ #67 | Buy | $420.00→ $435.00+3.6% |
|
Jul 31
00:43 UTC
|
ANIK
Anika Therapeutics
|
◎ Target | Anderson Schock ★★★★☆ #637 | Buy | $18.00→ $21.00+16.7% |
|
Jul 31
00:43 UTC
|
AML
Aston Martin Lagonda Global
|
◎ Target | firm only | Hold | GBX 45→ GBX 40-11.1% |
|
Jul 31
00:43 UTC
|
AMD
Advanced Micro Devices
|
◎ Target | Christopher Rolland ★★☆☆☆ #2620 | Positive | $450.00→ $500.00+11.1% |
|
Jul 31
00:43 UTC
|
ALNY
Alnylam Pharmaceuticals
|
◎ Target | Joseph Stringer ★★★☆☆ #1801 | Buy | $510.00→ $357.00-30.0% |
|
Jul 31
00:43 UTC
|
ALGM
Allegro MicroSystems
|
◎ Target | N. Quinn Bolton not yet tracked | Buy | $55.00→ $57.00+3.6% |
|
Jul 31
00:43 UTC
|
AGIO
Agios Pharmaceuticals
|
◎ Target | Emily Bodnar ★☆☆☆☆ #2989 | Buy | $52.00→ $55.00+5.8% |
|
Jul 31
00:43 UTC
|
AGI
Alamos Gold
|
◎ Target | firm only | C$82.00→ C$75.00-8.5% | |
|
Jul 31
00:43 UTC
|
AER
Aercap
|
◎ Target | Arren Cyganovich ★★★★☆ #675 | Buy | $175.00→ $180.00+2.9% |
|
Jul 31
00:43 UTC
|
AER
Aercap
|
◎ Target | Kristine Liwag ★★★☆☆ #1947 | Equal Weight | $155.00→ $165.00+6.5% |
|
Jul 31
00:43 UTC
|
AER
Aercap
|
◎ Target | John Godyn ★★★☆☆ #1234 | Buy | $173.00→ $178.00+2.9% |
|
Jul 31
00:43 UTC
|
ADPT
Adaptive Biotechnologies
|
◎ Target | Subbu Nambi ★★★★★ #44 | Buy | $22.00→ $25.00+13.6% |
|
Jul 31
00:43 UTC
|
ADPT
Adaptive Biotechnologies
|
◎ Target | Tejas Savant not yet tracked | Equal Weight | $20.00→ $22.00+10.0% |
|
Jul 31
00:43 UTC
|
ADPT
Adaptive Biotechnologies
|
◎ Target | Mark Massaro ★★★★★ #173 | Buy | $24.00→ $25.00+4.2% |
|
Jul 31
00:43 UTC
|
ADPT
Adaptive Biotechnologies
|
◎ Target | Dan Brennan not yet tracked | Buy | $25.00→ $28.00+12.0% |
|
Jul 31
00:43 UTC
|
ADP
Automatic Data Processing
|
◎ Target | Jason Kupferberg ★★★★☆ #868 | Equal Weight | $248.00→ $283.00+14.1% |
|
Jul 31
00:43 UTC
|
ADP
Automatic Data Processing
|
◎ Target | Jacob Smith not yet tracked | Buy | $270.00→ $300.00+11.1% |
|
Jul 31
00:43 UTC
|
ADP
Automatic Data Processing
|
◎ Target | David Grossman ★★★★★ #96 | Hold | $260.00→ $285.00+9.6% |
|
Jul 31
00:43 UTC
|
ADP
Automatic Data Processing
|
◎ Target | James Faucette ★★★☆☆ #1134 | Equal Weight | $240.00→ $286.00+19.2% |
|
Jul 31
00:43 UTC
|
ADP
Automatic Data Processing
|
◎ Target | Bryan Keane ★★★★☆ #530 | Neutral | $230.00→ $287.00+24.8% |
|
Jul 31
00:43 UTC
|
ADAM
Adamas Trust
|
◎ Target | Jason Weaver ★☆☆☆☆ #2959 | Buy | $9.50→ $10.00+5.3% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.